
	United States and Latin America		Canada		Europe, Middle East and Africa		Asia-Pacific		Total
Balance as of March 31, 2025	$	131,030	$	106,477	$	20,717	$	6,107	$	264,331

Foreign currency translation impact	—		5,467		1,765		227		7,459
Balance as of June 30, 2025	$	131,030	$	111,944	$	22,482	$	6,334	$	271,790

Goodwill is tested for impairment on an annual basis and between annual tests if indicators of potential impairment exist. We perform a qualitative analysis to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. If required, we also perform a quantitative analysis using the income approach, based on discounted future cash flows, which are derived from internal forecasts and economic expectations, and the market approach, which is based on market multiples of guideline public companies. The most significant inputs in the Company's quantitative goodwill impairment tests are projected financial information, the weighted average cost of capital and market multiples for similar transactions. Our annual impairment test is performed during the fourth quarter of our fiscal year. To date, there have been no indicators of impairment.


	Gross Carrying Amount at June 30, 2025		Accumulated Amortization		Net Carrying Amount at June 30, 2025		Gross Carrying Amount at March 31, 2025		Accumulated Amortization		Net Carrying Amount at March 31, 2025
Products	$	61,014	$	(46,777)	$	14,237	$	58,034	$	(43,042)	$	14,992
Trademarks	55,290		(4,156)		51,134		53,882		(3,838)		50,044
Developed technology	30,454		(9,713)		20,741		29,982		(9,010)		20,972
Customer relationships	138,659		(111,078)		27,581		135,679		(107,380)		28,299
Certifications	435		—		435		421		—		421
Other	1,280		(789)		491		1,280		(725)		555
Total	$	287,132	$	(172,513)	$	114,619	$	279,278	$	(163,995)	$	115,283